Shiga toxin 1 is a toxin family associated with some disease-causing bacteria. The stx1 entry on GI-MAP concerns a toxin-related gene target. A positive genetic target deserves clinical attention, but it does not measure the amount of active toxin in the intestine.
On this page
Why stx1 matters
Shiga toxin-producing E. coli (STEC) can cause serious diarrheal illness. Clinicians investigate possible STEC with testing for Shiga toxin or its genes and appropriate culture or laboratory confirmation. A toxin-gene result has a different meaning from a general Escherichia count. [1]
Reading stx1 with the rest of GI-MAP
Review stx1 alongside stx2, O157 and EPEC/EHEC. These are related pieces of the pathogen section, not four interchangeable names for one test. A stool panel can detect more than one target without proving that all targets belong to the same bacterial strain. [2]
What the result cannot predict
Detection alone cannot predict whether you will develop bloody diarrhea, how ill you will become or whether kidney complications will occur. A negative stx1 finding also does not make a positive stx2 result unimportant. Clinical assessment uses symptoms, hydration and, when indicated, blood tests—not a toxin-gene number as a severity score.
Why treatment needs a clinician
With suspected STEC, antibiotics or anti-motility medicines may increase the risk of complications in some circumstances. Do not use a positive marker to choose a medicine yourself. Contact a clinician promptly, particularly with bloody diarrhea or significant cramps. Reduced urination, unusual bruising or severe weakness warrants urgent care. [1]
Common questions
Is stx1 the same as a stool toxin protein test?
No. The genetic target and the toxin protein are different things. Check which method was used before comparing two reports.
Does stx1-negative mean the stool is free of pathogenic E. coli?
No. Other E. coli pathotypes and toxin targets can still be relevant. The whole panel and clinical history matter.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- CDC: Information for clinicians about E. coli
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.